About Arke Formulations Private Limited
Data last updated:
Arke Formulations Private Limited is a private limited company based in Rajkot, Gujarat, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 05 January 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ2000PTC037141. Its GSTIN is 24AADCA3443M1ZR (Gujarat).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors Kaushalbhai Vrajlal Dhuleshia and Jigneshkumar Shantilal Kantesaria.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dr Vikram Surabhai Nagargondal Road (South), Rajkot, Gujarat, India – 360004.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.66 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹9.18 Lakh (net margin 3.4%) and EBITDA of ₹14.57 Lakh (EBITDA margin 5.5%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 7% over five years.
As per MCA filings, the company has open charges of ₹50 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website arkeherbs.com.
Company details
Contact details
Arke Formulations Private Limited's registered office is in Rajkot, Gujarat. Its website is arkeherbs.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressDr Vikram Surabhai Nagargondal Road (South), Rajkot, Gujarat, India – 360004
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Arke Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Arke Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Arke Formulations Private Limited, buy the company report.
Financials of Arke Formulations Private Limited
FY 2025 filings availableArke Formulations Private Limited reported revenue of ₹2.66 Cr (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 8% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 7%. EBITDA fell 4% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.57 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9.18 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.5% | ||||
| Net Profit Margin | 3.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Arke Formulations Private Limited, buy the company report.
Board of directors of Arke Formulations Private Limited
Arke Formulations has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kaushalbhai Vrajlal Dhuleshia | Director | 29 Dec 2001 | 24 Years 10 Months | Current |
| Jigneshkumar Shantilal Kantesaria | Director | 25 Feb 2006 | 20 Years 8 Months | Current |
Auditor
Arke Formulations Private Limited is audited by B A SHAH ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B A SHAH ASSOCIATES | FY 2021 | 109493W |
Shareholding
The shareholding of Arke Formulations Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Arke Formulations Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 May 2021 | 100462892 | Others | ₹50 Lakh | Open |
To see the full charge records of Arke Formulations Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Arke Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Arke Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Arke Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AADCA3443M1ZR | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Arke Formulations Private Limited, buy the company report.
Recent activity
Arke Formulations Private Limited has 6 board changes on record since 2001: 2 appointments and 4 cessations. The latest: Jigneshkumar Shantilal Kantesaria ceased to be Director on 07 May 2017.
Frequently asked questions
Arke Formulations is an active private limited company based in Rajkot, Gujarat, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 05 January 2000 (26+ years old) and is registered under CIN U24231GJ2000PTC037141.
Arke Formulations has 2 current directors:
- Kaushalbhai Vrajlal Dhuleshia - Director
- Jigneshkumar Shantilal Kantesaria - Director
The latest financial statements of Arke Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Arke Formulations is 24AADCA3443M1ZR, registered in Gujarat.
The CIN (Corporate Identification Number) of Arke Formulations is U24231GJ2000PTC037141. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arke Formulations was incorporated on 05 January 2000, making it 26+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Jigneshkumar Shantilal Kantesaria ceased to be Director on 07 May 2017. Kaushalbhai Vrajlal Dhuleshia ceased to be Director on 07 May 2017. Hasit Nandlal Kantesaria ceased to be Director on 10 Mar 2010. Arke Formulations has 6 board changes on record in total.
Arke Formulations can be reached through the website arkeherbs.com. Its registered office is in Rajkot, Gujarat, India.
The registered office of Arke Formulations is at Dr Vikram Surabhai Nagargondal Road South, Rajkot, Gujarat, India – 360004.
Arke Formulations operates in the healthcare industry, in the ayurvedic products and services segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
